Clinical trials
13 active studies led by Vigonvita Life Sciences, of 39 in all
Source: ClinicalTrials.gov, Studies with Vigonvita Life Sciences (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- 13Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Vigonvita Life Sciences or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Vigonvita Life Sciences
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies Vigonvita Life Sciences leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Vigonvita Life Sciences or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Vigonvita Life Sciences: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Vigonvita Life Sciences is in.
From our blog
Stories on the topics Vigonvita Life Sciences works in.
Adaptogens: Ancient Herbs, Modern Market
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Stress and Mood Supplements: Ashwagandha and Beyond
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
Antidepressants: Demand, Access and New Approaches
About 322 million people live with depression. Treatment works, but most people still do not get it.
ReadSearch all reports for Vigonvita Life Sciences All companies